'Lone' atrial fibrillation: Hunting for the underlying causes and links

International Journal of Cardiology

Volumn 131, Issue 2, 2009, Pages 180-185

  Korantzopoulos, Panagiotis ^a   Liu, Tong ^b   Milionis, Haralampos J ^a   Li, Guangping ^b   Goudevenos, John A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b Second Hospital   (China)

Author keywords

Epidemiology; Etiology; Genetics; Lone atrial fibrillation; Pathogenesis; Pathophysiology

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIARRHYTHMIC AGENT; CARDIOTONIC AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CHOLINERGIC RECEPTOR STIMULATING AGENT; CYTOSTATIC AGENT; XANTHINE DERIVATIVE;

ALCOHOL CONSUMPTION; ANGER; ATHEROSCLEROSIS; DIABETES MELLITUS; GENETIC LINKAGE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HOSTILITY; HUMAN; INFLAMMATION; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PULSE PRESSURE; REVIEW; SLEEP APNEA SYNDROME;

ATRIAL FIBRILLATION; HEART DEFECTS, CONGENITAL; HUMANS; HYPERTENSION; RISK FACTORS;

EID: 57549116218     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2008.06.035     Document Type: Review

References (66)

1. Chen L.Y., and Shen W.K. Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm 4 (2007) S1-S6
2. Lip G.Y.H., and Watson T. Atrial fibrillation - the growing epidemic. Heart 93 (2007) 542-543
3. Korantzopoulos P., Kolettis T.M., Goudevenos J.A., and Siogas K. Errors and pitfalls in the non-invasive management of atrial fibrillation. Int J Cardiol 104 (2005) 125-130
4. Gersh B.J., and Solomon A. Lone atrial fibrillation: epidemiology and natural history. Am Heart J 137 (1999) 592-595
5. Fuster V., Ryden L.E., Cannom D.S., et al. American College of Cardiology; American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Europace 8 (2006) 651-745
6. Levy S., Camm A.J., Saksena S., et al. International consensus on nomenclature and classification of atrial fibrillation; a collaborative project of the Working Group on Arrhythmias and the Working Group on Cardiac Pacing of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Europace 5 (2003) 119-122
7. Jahangir A., Lee V., Friedman P.A., et al. Long-term progression and outcomes with aging in patients with lone atrial fibrillation. A 30-year follow-up study. Circulation 115 (2007) 3050-3056
8. Thrall G., Lane D., Carroll D., and Lip G.Y. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med 119 448 (2006) e1-19
9. Lorbar M., and Spodick D.H. 'Idiopathic' pericarditis - the clinician's challenge [nothing is idiopathic]. Int J Clin Pract 61 (2007) 138-142
10. Van Wagoner D.R. Recent insights into the pathophysiology of atrial fibrillation. Semin Thorac Cardiovasc Surg 19 (2007) 9-15
11. Frost L. Lone atrial fibrillation: good, bad, or ugly?. Circulation 115 (2007) 3040-3041
12. Shiroshita-Takeshita A., Brundel B.J.J.M., and Nattel S. Atrial fibrillation: basic mechanisms, remodeling, and triggers. J Interv Card Electrophysiol 13 (2005) 181-193
13. Wang T.J., and Benjamin E.J. The epidemiology of atrial fibrillation. In: Kowey P., and Naccarelli G.V. (Eds). Atrial fibrillation (2005), Marcel Dekker, New York 1-26
14. Gami A.S., Hodge D.O., Herges R.M., et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol 49 (2007) 565-571
15. Dublin S., French B., Glazer N.L., et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med 166 (2006) 2322-2328
16. Movahed M.R., Hashemzadeh M., and Jamal M.M. Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease. Int J Cardiol (2005) 105:315-318
17. Umetani K., Kodama Y., Nakamura T., et al. High prevalence of paroxysmal atrial fibrillation and/or atrial flutter in metabolic syndrome. Circ J 71 (2007) 252-255
18. Frost L., and Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med 164 (2004) 1993-1998
19. Eaker E.D., Sullivan L.M., Kelly-Hayes M., D'Agostino Sr. R.B., and Benjamin E.J. Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study. Circulation 109 (2004) 1267-1271
20. Mitchell G.F., Vasan R.S., Keyes M.J., et al. Pulse pressure and risk of new-onset atrial fibrillation. JAMA 297 (2007) 709-715
21. Heeringa J., van der Kuip D.A., Hofman A., et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 167 (2007) 382-387
22. Katritsis D.G., Toumpoulis I.K., Giazitzoglou E., et al. Latent arterial hypertension in apparently lone atrial fibrillation. J Interv Card Electrophysiol 13 (2005) 203-207
23. Patton K.K., Zacks E.S., Chang J.Y., et al. Clinical subtypes of lone atrial fibrillation. Pacing Clin Electrophysiol 28 (2005) 630-638
24. Chambers P.W. Lone atrial fibrillation: pathologic or not?. Med Hypotheses 68 (2007) 281-287
25. Chen J., Wasmund S.L., and Hamdan M.H. Back to the future: the role of the autonomic nervous system in atrial fibrillation. Pacing Clin Electrophysiol 29 (2006) 413-421
26. Podrid P.J. Etiology and pathogenesis of atrial fibrillation. In: Kowey P., and Naccarelli G.V. (Eds). Atrial fibrillation (2005), Marcel Dekker, New York 27-60
27. Mont L., Sambola A., Brugada J., et al. Long-lasting sport practice and lone atrial fibrillation. Eur Heart J 23 (2002) 477-482
28. Elosua R., Arquer A., Mont L., et al. Lone atrial fibrillation and sport practice. The no gain without pain history revisited again?. Int J Cardiol 118 (2007) 414-415
29. van der Hooft C.S., Heeringa J., van Herpen G., Kors J.A., Kingma J.H., and Stricker B.H. Drug-induced atrial fibrillation. J Am Coll Cardiol 44 (2004) 2117-2124
30. Tsang T.S., Gersh B.J., Appleton C.P., et al. Left ventricular diastolic dysfunction as a predictor of the first diagnosed nonvalvular atrial fibrillation in 840 elderly men and women. J Am Coll Cardiol 40 (2002) 1636-1644
31. Li J., and Wang L. B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels 21 (2006) 137-140
32. Lee S.H., Jung J.H., Choi S.H., et al. Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circ J 70 (2006) 100-104
33. Osranek M., Bursi F., Bailey K.R., et al. Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up. Eur Heart J 26 (2005) 2556-2561
34. Sitges M., Teijeira V.A., Scalise A., et al. Is there an anatomical substrate for idiopathic paroxysmal atrial fibrillation? A case-control echocardiographic study. Europace 9 (2007) 294-298
35. Phang R.S., Isserman S.M., Karia D., et al. Echocardiographic evidence of left atrial abnormality in young patients with lone paroxysmal atrial fibrillation. Am J Cardiol 94 (2004) 511-513
36. Kosmala W., Przewlocka-Kosmala M., and Mazurek W. Abnormalities of pulmonary venous flow in patients with lone atrial fibrillation. Europace 8 (2006) 102-106
37. Reant P., Lafitte S., Jais P., et al. Reverse remodeling of the left cardiac chambers after catheter ablation after 1 year in a series of patients with isolated atrial fibrillation. Circulation 112 (2005) 2896-2903
38. Nanthakumar K., Lau Y.R., Plumb V.J., Epstein A.E., and Kay G.N. Electrophysiological findings in adolescents with atrial fibrillation who have structurally normal hearts. Circulation 110 (2004) 117-123
39. Todd D.M., Skanes A.C., Guiraudon G., et al. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 108 (2003) 3108-3114
40. Haïssaguerre M., Jaïs P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
41. Lin W.S., Tai C.T., Hsieh M.H., et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 107 (2003) 3176-3183
42. Chou C.C., and Chen P.S. New concepts in atrial fibrillation: mechanism and remodeling. Med Clin North Am 92 (2008) 53-63
43. Wiesfeld A.C., Hemels M.E., Van Tintelen J.P., Van den Berg M.P., Van Veldhuisen D.J., and Van Gelder I.C. Genetic aspects of atrial fibrillation. Cardiovasc Res 67 (2005) 414-418
44. Fox C.S., Parise H., D'Agostino Sr. R.B., et al. Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring. JAMA 291 (2004) 2851-2855
45. Darbar D., Herron K.J., Ballew J.D., et al. Familial atrial fibrillation is a genetically heterogeneous disorder. J Am Coll Cardiol 41 (2003) 2185-2192
46. Ellinor P.T., Yoerger D.M., Ruskin J.N., and MacRae C.A. Familial aggregation in lone atrial fibrillation. Hum Genet 118 (2005) 179-184
47. Kato K., Oguri M., Hibino T., et al. Genetic factors for lone atrial fibrillation. Int J Mol Med 19 (2007) 933-939
48. Fatkin D., Otway R., and Vandenberg J.I. Genes and atrial fibrillation: a new look at an old problem. Circulation 116 (2007) 782-792
49. Firouzi M., Ramanna H., Kok B., et al. Association of human connexin40 gene polymorphisms with atrial vulnerability as a risk factor for idiopathic atrial fibrillation. Circ Res 95 (2004) e29-33
50. Gollob M.H., Jones D.L., Krahn A.D., et al. Somatic mutations in the connexin 40 gene (GJA5) in atrial fibrillation. N Engl J Med 354 (2006) 2677-2688
51. Tsai C.T., Lai L.P., Lin J.L., et al. Renin-angiotensin system gene polymorphisms and atrial fibrillation. Circulation 109 (2004) 1640-1646
52. Fatini C., Sticchi E., Gensini F., et al. Lone and secondary nonvalvular atrial fibrillation: role of a genetic susceptibility. Int J Cardiol 120 (2007) 59-65
53. Chen L.Y., Ballew J.D., Herron K.J., Rodeheffer R.J., and Olson T.M. A common polymorphism in SCN5A is associated with lone atrial fibrillation. Clin Pharmacol Ther 81 (2007) 35-41
54. Morita H., Kusano-Fukushima K., Nagase S., et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 40 (2002) 1437-1444
55. Letsas K.P., Sideris A., Efremidis M., et al. Prevalence of paroxysmal atrial fibrillation in Brugada syndrome: a case series and a review of the literature. J Cardiovasc Med 8 (2007) 803-806
56. Junttila M.J., Raatikainen M.J., Perkiömäki J.S., Hong K., Brugada R., and Huikuri H.V. Familial clustering of lone atrial fibrillation in patients with saddleback-type ST-segment elevation in right precordial leads. Eur Heart J 28 (2007) 463-468
57. Poglajen G., Fister M., Radovancevic B., and Vrtovec B. Short QT interval and atrial fibrillation in patients without structural heart disease. J Am Coll Cardiol 47 (2006) 1905-1907
58. Ehrlich J.R., Hohnloser S.H., and Nattel S. Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence. Eur Heart J 27 (2006) 512-518
59. Ellinor P.T., Low A.F., and Macrae C.A. Reduced apelin levels in lone atrial fibrillation. Eur Heart J 27 (2006) 222-226
60. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
61. Liu T., Li G., Li L., and Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49 (2007) 1642-1648
62. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
63. Ellinor P.T., Low A., Patton K.K., Shea M.A., and MacRae C.A. C-reactive protein in lone atrial fibrillation. Am J Cardiol 97 (2006) 1346-1350
64. Hatzinikolaou-Kotsakou E., Tziakas D., Hotidis A., et al. Relation of C-reactive protein to the first onset and the recurrence rate in lone atrial fibrillation. Am J Cardiol 97 (2006) 659-661
65. Gedikli O., Dogan A., Altuntas I., et al. Inflammatory markers according to types of atrial fibrillation. Int J Cardiol 120 (2007) 193-197
66. Maixent J.M., Paganelli F., Scaglione J., and Lévy S. Antibodies against myosin in sera of patients with idiopathic paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol 9 (1998) 612-617